The National Cancer Institute (NCI) is offering this grant to stimulate early-phase (Phase I and II) clinical trials in cancer immunotherapy. This funding opportunity aims to establish a Cancer Immunotherapy Trials Network (CITN), focusing on high-priority immunotherapy agents and combination therapies identified at the 2007 NCI workshop. The grant is specifically for a single award to create a Central Operations and Statistical Center (COSC) for the CITN. This COSC will provide overall leadership, statistical support, and protocol coordination for the network. The CITN will comprise up to 25 Member Sites conducting trials, supported by associated tumor immunology laboratories for standardized immunomonitoring and biomarker studies. The NCI will provide data coordinating services, ensuring comprehensive support for advancing cancer immunotherapy.
Opportunity ID: 50439
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | RFA-CA-10-007 |
| Funding Opportunity Title: | Cancer Immunotherapy Trials Network (U01) |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Cooperative Agreement |
| Category of Funding Activity: | Education Health |
| Category Explanation: | – |
| Expected Number of Awards: | – |
| Assistance Listings: | 93.395 — Cancer Treatment Research |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 1 |
| Posted Date: | Dec 01, 2009 |
| Last Updated Date: | – |
| Original Closing Date for Applications: | Feb 19, 2010 |
| Current Closing Date for Applications: | Feb 19, 2010 |
| Archive Date: | Mar 22, 2010 |
| Estimated Total Program Funding: | – |
| Award Ceiling: | – |
| Award Floor: | – |
Eligibility
| Eligible Applicants: | Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Public and State controlled institutions of higher education Private institutions of higher education Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education |
| Additional Information on Eligibility: | – |
Additional Information
| Agency Name: | National Institutes of Health |
| Description: | Purpose. The purpose of this funding opportunity announcement (FOA) is to stimulate the conduct of early (Phase I and Phase II) clinical trials in the area of cancer immunotherapy by forming a Cancer Immunotherapy Trials Network (CITN). The emphasis is on clinical trials of high priority agents that were identified at the 2007 NCI immunotherapy agent workshop and on clinical trials using combinations of immunotherapy modalities and other agents. The CITN will support a multi-investigator team assembled to bring new immunotherapy agents to the clinic. This support will be realized through a single award for a Central Operations and Statistical Center (COSC) of the CITN. Whereas this FOA solicits applications specifically for the CITN COSC, the awardee team and their Program Directors/Principal Investigators (PDs/PIs) will provide overall leadership and statistical and protocol coordinator support for the CITN program. COSC applicants must plan that the CITN will include the following additional elements : (1) up to 25 institutions that will conduct the clinical trials as CITN Member Sites (supported through subcontracts within the COSC award); (2) support for tumor immunology laboratories that are associated with the Member Sites to conduct standardized immunomonitoring assays and biomarker and correlative studies related to the clinical trials; and (3) a data coordinating service that will be provided by a unit operated by the NCI (which remains beyond the scope of solicited applications). |
| Link to Additional Information: | http://grants.nih.gov/grants/guide/rfa-files/RFA-CA-10-007.html |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV Email:FBOWebmaster@OD.NIH.GOV |
Version History
| Version | Modification Description | Updated Date |
|---|---|---|
Related Documents
There are no related documents on this grant.
Packages
There are no packages on this grant.
Share This Post, Choose Your Platform!
About the Author: osnqt
